• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-Deoxy-D-Glucose (2DG)
      • Acacia Cyanophylla Flower
      • Acori Graminei Rhizoma
      • Aegle Marmelos Correa
      • Agaricus Blazei
      • Aged Garlic Extract
      • Aframomum Melegueta
      • Aloe Arborescens
      • Albizia
      • Alpinia Officinarum
      • Alternanthera Sessilis
      • American Ginseng
      • Amygdalin
      • Anacyclus Pyrethrum
      • Angelica Archangelica
      • Angelica Sinensis
      • Antrodia
      • Artichoke Leaf
      • Artocarpin
      • Ajuga Turkestanica
      • Ashwagandha
      • Aspalathin
      • Astragalus Complanatus
      • Avena Sativa
      • Bacopa Monnieri
      • Bavachin
      • Bee Pollen
      • Betulinic Acid
      • Boswellic Acid
      • Brevilin A
      • Campesterol
      • Casticin
      • Chrysin
      • Cinnamomum Zeylanicum
      • Citrullus Colocynthis
      • Citrus Reticulata Peel
      • Codonopsis
      • Costunolide
      • Cucurbitacin D
      • Daidzein
      • Decursin
      • Delphinidin
      • Digitalis Purprea (Digoxin)
      • Diosmin
      • Embelin
      • Gallic Acid
      • Glycitein
      • Glycyrrhizin
      • Hyperforin
      • Icariin
      • Isorhamnetin
      • Isoorientin
      • Isovitexin
      • Jaceosidin
      • Kaempferol
      • Kurarinone
      • Lemon balm
      • Licoricidin
      • Lipoic acid
      • Lupeol
      • Magnolol
      • Mulberry Leaf
      • Naringenin
      • Nobiletin
      • Oleacein
      • Oleanolic acid
      • Oridonin
      • Parthenolide
      • Phloroglucinol
      • Piceatannol
      • Pristimerin
      • Proanthocyanidins
      • Procyanidin B3
      • Pseudolaric acid b
      • Pterostilbene
      • Rutin
      • Solidago Virgaurea
      • Tangeretin
      • Taraxasterol
      • Trichostatin A
      • Wedelolactone
      • Wogonin
      • Yerba Mate
    • ABOUT
    • SCIENTIFIC STUDIES
      • ALLERGIES & CYTOKINES
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • AMPK
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • APOPTOSIS
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • CARDIAC GLYCOSIDES
      • CENTENARIANS
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • EPIGENETIC MODIFIERS
      • FGF21
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HMGB1
      • HSP90 INHIBITORS
      • HYPERINSULINEMIA
      • IKK
      • IL-6/STAT3
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INSULIN & AGING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MSG (MONOSOSODIUM GLUTAMATE)
      • mTOR: THE RAPID AGING PATHWAY
      • NEUROINFLAMMATION
      • NMDA & ANXIETY & DEPRESSION
      • NOOTROPICS
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PPARY2
      • PREMATURE SENESCENCE
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAT3
      • TELOMERE SHORTENING & PREMATURE AGING
    • HOME
    • FAQ
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    INFLAMMAGING
    January 29, 2020
    DELPHINIDIN
    January 29, 2020
    1. (S)-(+)-Decursin and its Analogues as Inhibitors of Cytokines Secretion Induced by DpE in THP-1/EoL-1 Cell Line
    2. [P8-06] Effect of Decursin on the Body weight and Glucose tolerance in C57/BL/6 Mice Fed High Fat Diet
    3. 183: Decursin affects Wnt/beta catenin pathway on prostate cancer cell lines.
    4. 3D-QSAR Study of Melanin Inhibiting (S)-(+)-Decursin and its Analogues by Pharmacophore Mapping
    5. A (S)-(+)-Decursin derivative,(S)-(+)-3-(3, 4-dihydroxy-phenyl)-acrylic acid 2, 2-dimethyl-8-oxo-3, 4-dihydro-2H, 8H-pyrano [3, 2-g]-chromen-3-yl-ester, attenuates the …
    6. A COMPOSITION COMPRISING NOVEL (+)-Decursin-ETHER DERIVATIVE FOR TREATING AND PREVENTING ATOPIC DERMATITIS DISEASE
    7. A novel (S)-(+)-Decursin derivative,(S)-(+)-3-(3, 4-dihydroxy-phenyl)-acrylic acid 2, 2-dimethyl-8-oxo-3, 4-dihydro-2H, 8H-pyrano [3, 2-g] chromen-3-yl-ester, inhibits …
    8. A novel anticancer agent, Decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells
    9. A novel anticancer agent, Decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells: Yim D, Singh RP, Agarwal C, Lee S, Chi H, Agarwal R …
    10. A novel anticancer agent, Decursin, induces G1 arrest and apoptosis in human prostate carcinoma DU145 cells
    11. A Novel Anticancer Agent, Decursin, Induces G1 Arrest in Human Prostate Carcinoma DU-145
    12. A novel derivative of Decursin, CSL‐32, blocks migration and production of inflammatory mediators and modulates PI3K and NF‐κB activities in HT1080 cells
    13. A synthetic Decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo
    14. Absorption, distribution, metabolism, and excretion of Decursin and Decursinol angelate from Angelica gigas Nakai
    15. Abstract LB-428: Decursin inhibits advanced human prostate tumor xenograft growth involving antiproliferative and antiangiogenic mechanisms
    16. Analytical Validation of Decursin in Aerial Parts of Angelica gigas Nakai
    17. Angelica gigas Nakai and Decursin downregulate Myc expression to promote cell death in B-cell lymphoma
    18. Anti-Angiogenic Effect of Decursin on Retinal Neovasularization of Oxygn-Induced Retinopathy
    19. Anti-tumor activities of Decursinol angelate and Decursin fromAngelica gigas
    20. Antibacterial activity of Decursin from Streptomyces sp. GMT-8; an endophyte in Zingiber officinale Rosc.
    21. Availability of Decursin and Decursinol Angelate and antioxidant activity in the seeds of Angelica gigas Nakai
    22. Axial conformation of 3-methyl-2-butenoyl group in pyranocoumarin ring endows biological activity of (+)-Decursin
    23. Biopharmaceutical characterization of Decursin and their derivatives for drug discovery
    24. Biotransformation of plant secondary metabolite Decursin by Mycobacterium sp. PYR1001
    25. Changes in the growth characteristics and the content of Decursin and Decursinol angelate in Angelica gigas Nakai by mineral and hormonal agent treatment
    26. Cognitive-Enhancing Activity of Decursin Derivatives
    27. Comparison of skin sensitization potentials of Decursin with different purities by evaluating the expression of surface markers on THP-1 cells (초)
    28. Compositions for urinary dysfunction and edema containing Decursin and/or Decursinol angelate, or angelica extract containing Decursin and/or Decursinol angelate
    29. Computational approaches to predict binding interactions between mammalian tyrosinases and (S)-(+)-Decursin and its analogues as potent inhibitors
    30. Cytochrome P450 isoforms in the metabolism of Decursin and Decursinol angelate from Korean Angelica
    31. Decursin and Decursinol angelate affect spermatogenesis in the adult rat at oral administration
    32. Decursin and Decursinol angelate from Angelica gigas Nakai induce apoptosis via induction of TRAIL expression on cervical cancer cells
    33. Decursin and Decursinol angelate improve wound healing by upregulating transcription of genes encoding extracellular matrix remodeling proteins, inflammatory …
    34. Decursin and Decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells
    35. Decursin and Decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells
    36. Decursin and Decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway
    37. Decursin and Decursinol angelate selectively inhibit NADH-fumarate reductase of Ascaris suum
    38. Decursin and Decursinol Angelate Suppress Adipogenesis through Activation of β-catenin Signaling Pathway in Human Visceral Adipose-Derived Stem Cells
    39. Decursin and Decursinol angelate-rich Angelica gigas Nakai extract suppresses de novo lipogenesis and alleviates nonalcoholic fatty liver disease and dyslipidemia …
    40. Decursin and Decursinol angelate: molecular mechanism and therapeutic potential in inflammatory diseases
    41. Decursin and Decursinol from Angelica gigas Inhibit the Lung Metastasis of Murine Colon Carcinoma
    42. Decursin and Decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase
    43. Decursin and doxorubicin are in synergy for the induction of apoptosis via STAT3 and/or mTOR pathways in human multiple myeloma cells
    44. Decursin and doxorubicin are in synergy for the induction of apoptosis via STAT3 and/or mTOR pathways in human multiple myeloma cells.
    45. Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells
    46. Decursin and Z-ligustilide in Angelica tenuissima root extract fermented by Aspergillus oryzae display anti-pigment activity in melanoma cells
    47. Decursin Attenuate CCl4-induced Liver Fibrogenesis
    48. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD (P) H oxidase activation and Smad signaling in vivo and in vitro
    49. Decursin attenuates the amyloid‐β‐induced inflammatory response in PC12 cells via MAPK and nuclear factor‐κB pathway
    50. Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway
    51. Decursin derivative-004 protect renal cell damage via p38 MARK inhibition
    52. Decursin derivatives with increased in vivo stability suppress androgen receptor signaling and prostate cancer cell growth: Structure-bioactivity relationship
    53. Decursin enhances TRAIL‐induced apoptosis through oxidative stress mediated‐endoplasmic reticulum stress signalling in non‐small cell lung cancers
    54. Decursin exerts anti‐cancer activity in MDA‐MB‐231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association
    55. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice
    56. Decursin from Angelica gigas Nakai Blocks hKv1. 5 Channel
    57. Decursin from Angelica gigas Nakai induces apoptosis in RC-58T/h/SA# 4 primary human prostate cancer cells via a mitochondria-related caspase pathway
    58. Decursin from Angelica gigas Nakai Inhibits B16F10 Melanoma Growth Through Induction of Apoptosis
    59. Decursin from Angelica gigas Nakai regulates CXCR7 expression and its downstream signaling in gastric cancer cells
    60. Decursin from Angelica gigas suppresses RANKL-induced osteoclast formation and bone loss
    61. Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR‐RES Ovarian Cancer Cells via Inhibition of P‐glycoprotein Expression
    62. Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADRâ RES Ovarian Cancer Cells via Inhibition of Pâ glycoprotein Expression
    63. Decursin induces apoptosis by regulating AMP-activated protein kinase and Bax/Bcl-2 pathway in HepG2 cell line
    64. Decursin induces apoptosis in glioblastoma cells, but not in glial cells via a mitochondria-related caspase pathway
    65. Decursin inhibited proliferation and angiogenesis of endothelial cells to suppress diabetic retinopathy via VEGFR2
    66. Decursin inhibits EC109 cells proliferation via suppression of JAK2/STAT3 signaling pathway
    67. Decursin inhibits growth of human bladder and colon cancer cells via apoptosis, G1-phase cell cycle arrest and extracellular signal-regulated kinase activation
    68. Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-κB activation in macrophages
    69. Decursin inhibits osteoclastogenesis by downregulating NFATc1 and blocking fusion of pre-osteoclasts
    70. Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation
    71. Decursin inhibits the growth of HepG2 hepatocellular carcinoma cells via Hippo/YAP signaling pathway
    72. Decursin inhibits tumor growth, migration and invasion through the regulation of CXCR7 expression in gastric cancer
    73. Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression
    74. Decursin inhibits UVB-induced MMP expression in human dermal fibroblasts via regulation of nuclear factor-κB
    75. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function
    76. Decursin Inhibits VEGF-Mediated Inner Blood-Retinal Barrier Breakdown by Suppression of VEGFR-2 Activation
    77. Decursin Inhibits VEGF-mediated inner blood—retinal barrier breakdown by suppression of VEGFR-2 activation
    78. Decursin isolated from Angelica gigas Nakai rescues PC12 cells from amyloid-protein-induced neurotoxicity through Nrf2-mediated upregulation of heme oxygenase …
    79. Decursin mediated protection on cisplatin-induced nephrotoxicity in SD rats and BDF1 mice
    80. Decursin prevents cisplatin-induced apoptosis via the enhancement of antioxidant enzymes in human renal epithelial cells
    81. Decursin prevents TPA-induced invasion through suppression of PKCα/p38/NF-κB-dependent MMP-9 expression in MCF-7 human breast carcinoma cells
    82. Decursin reduce radio-resistance of hypoxic regions under the proton beam therapy by induced HIF-1α degradation
    83. Decursin reduces reactive oxygen species and inhibits cisplatin-induced apoptosis in rat renal tubular epithelial cells
    84. Decursin safety from root of Angelica gigas in rats
    85. Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of β-catenin
    86. Decursin synergistically enhances TRAIL-induced apoptosis through CHOP dependent DR5 signaling in TRAIL resistant lung cancer cells
    87. Decursin was Accelerated Human Lung Cancer Cell Death Caused by Proton Beam Irradiation via Blocking the p42/44 MAPK pathway
    88. Decursin, a coumarin compound, inhibits the growth of human hepatoma cells involving cell cycle arrest, apoptosis, and autophagy
    89. Decursin, an Active Compound Isolated from Angelica gigas, Inhibits Fat Accumulation, Reduces Adipocytokine Secretion and Improves Glucose Tolerance in Mice …
    90. Decursin, Decursinol angelate Decursinol inhibit pro-inflammatory cytokine expression on β-amyloid peptide-induced THP-1 cells
    91. Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas
    92. Decursinol and Decursin protect primary cultured rat cortical cells from glutamate‐induced neurotoxicity
    93. Determination of Decursin from eight kinds of Angelica plants by HPLC [J]
    94. Determination of pyranocoumarin compounds Decursin, Decursinol angelate and Decursinol simultaneously in mouse plasma and tumor tissue by liquid-liquid …
    95. Discovery of Decursin from Korean Angelica gigas as a novel anti-androgen signaling compound
    96. Effect of a (S)-(+)-Decursin Derivative,(S)-(+)-3-(3, 4-dihydroxy-phenyl)-acrylic Acid 2, 2-dimethyl-8-oxo-3, 4-dihydro-2H, 8H-pyrano [3, 2-g]-chromen-3-yl-ester on …
    97. Effect of Decursin on the Expression of β-Catenin and Matrix Metalloproteinase-7 in Prostate Cancer Cell Lines
    98. Effect of Decursin on the pharmacokinetics of theophylline and its metabolites in rats
    99. Effect of N, P and K Application on the Contents of the Decursin and Total Sugar in Angelicae gigantis Radix
    100. Effect of yield and Decursin content according to the accumulative temperature and seedling size in cultivation areas of Angelica gigas Nakai
    101. Effects of Angelica gigas Nakai on the production of Decursin‐ and Decursinol angelate‐enriched eggs
    102. Effects of Decursin and Decursinol on the germination and growth of plants
    103. Enantioselective syntheses of Decursinol angelate and Decursin
    104. Enantioselective total syntheses of (+)-Decursin and related natural compounds using catalytic asymmetric epoxidation of an enone
    105. Enantioselective total syntheses of novel PKC activator (+)-Decursin and its derivatives using catalytic asymmetric epoxidation of an enone
    106. Enhanced accumulation of Decursin and Decursinol angelate in root cultures and intact roots of Angelica gigas Nakai following elicitation
    107. Environmental variation of Decursin content in Angelica gigas
    108. Erratum to ”Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid 𝛽-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of …
    109. Erratum to “Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid β-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of …
    110. Far infared effect on Decursin, Decursinol angelate and antioxidant activity in Angelica gigas Nakai
    111. First-pass metabolism of Decursin, a bioactive compound of Angelica gigas, in rats
    112. First-pass metabolism of Decursin, a bioactive compound of Angelica gigas, in rats
    113. Hypopigmentary action of dihydropyranocoumarin D2, a Decursin derivative, as a MITF-degrading agent
    114. In vitro and in vivo antifungal activities of Decursin and Decursinol angelate isolated from Angelica gigas against Magnaporthe oryzae, the causal agent of rice blast
    115. In Vitro inhibitory potential of Decursin and Decursinol angelate on the catalytic activity of cytochrome P-450 1A1/2, 2D15, and 3A12 isoforms in canine hepatic …
    116. In vitro metabolism of pyranocoumarin isomers Decursin and Decursinol angelate by liver microsomes from man and rodents
    117. In vivo Anti-Cancer Activity of Korean Angelica Gigas and its Major Pyranocoumarin Decursin
    118. Inhibition of angiogenic attributes by Decursin in endothelial cells and ex vivo rat aortic ring angiogenesis model
    119. Inhibition of cyclooxygenase-2-dependent survivin mediates Decursin-induced apoptosis in human KBM-5 myeloid leukemia cells
    120. Inhibitory Effect of Decursin on Retinal Neovasularization in Mouse Model of Oxygn-induced Retinopathy
    121. Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic Decursin and its derivatives and their structure–activity relationship in human K562 …
    122. Microbial metabolism. Part 8. The pyranocoumarin, Decursin
    123. MP70-14 EFFECTS OF Decursin EXTRACTED FROM ANGELICA GIGAS VIA NRF2/HO-1 SIGNALLING PATHWAY IN CRYPTORCHIDISM-INDUCED …
    124. New syntheses of demethylsuberosin, xanthyletin,(±)-Decursinol,(+)-marmesin,(−)-nodakenetin,(±)-Decursin, and (±)-prantschimgin
    125. NF-E2 related factor 2 activation induction by Decursin and Decursinol angelate protect against bete-amyloid-peptide-induced oxidative stress in PC12 cells
    126. Optimal Extraction and Purification of Decursin from Angelica gigas Nakai
    127. PHARMACEUTICAL AND COSMETIC COMPOSITION COMPRISING OF Decursin FOR INCREASING THE NUMBERS OF HUMAN KERATINOCYTE …
    128. Pharmacokinetic Study of Decursin, the Major Compound of ESP-102, in Rats
    129. Physicochemical characterization and toxicity of Decursin and their derivatives from Angelica gigas
    130. Pilot-scale subcritical-water extraction of nodakenin and Decursin from Angelica gigas Nakai
    131. Potent antiandrogen and androgen receptor activities of an Angelica gigas–containing herbal formulation: identification of Decursin as a novel and active compound …
    132. Potent inhibition of monoamine oxidase A by Decursin from Angelica gigas Nakai and by wogonin from Scutellaria baicalensis Georgi
    133. Potential of Decursin to inhibit the human cytochrome P450 2J2 isoform
    134. Profiling of skin anti-aging related proteins in human dermal fibroblasts by Decursin in Angelica gigas Nakai
    135. Protective effect of Decursin and Decursinol angelate-rich Angelica gigas Nakai extract on dextran sulfate sodium-induced murine ulcerative colitis
    136. Protective effect of Decursin extracted from Angelica gigas in male infertility via Nrf2/HO-1 signaling pathway
    137. Protective effects of Decursin and Decursinol angelate against amyloid β-protein-induced oxidative stress in the PC12 cell line: the role of Nrf2 and antioxidant …
    138. Quantitative determination of Decursin, Decursinol angelate, and Decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC
    139. Rapid and Efficient Separation of Decursin and Decursinol Angelate from Angelica gigas Nakai using Ionic Liquid,(BMIm) BF4, Combined with Crystallization
    140. Recovery from the two-generation reproductive toxicity in sprague-dawley rats by treatment with Decursin and Decursinol angelate
    141. Retracted: Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid β-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of …
    142. Role of Decursin in TNF-α-stimulated migration, invasion, and matrix metalloproteinase-9 induction in vascular smooth muscle cells
    143. Simultaneous determination of Decursin, Decursinol angelate, nodakenin, and Decursinol of angelica gigas nakai in human plasma by UHPLC-MS/MS: application to …
    144. Single oral dose pharmacokinetics of Decursin and Decursinol angelate in healthy adult men and women
    145. Single oral dose pharmacokinetics of Decursin, Decursinol angelate, and Decursinol in rats
    146. Stereostructures of Decursin, decursidin, and a new coumarin isolated from Angelica decursiva
    147. Studies on coumarins from the root of Angelica decursiva FR. et SAV. I. The structure of Decursin and decursidin
    148. Studies on coumarins from the root of Angelica decursiva FR. et SAV. II. Sterostructures of Decursin, decursidin, and other new pyranocoumarin derivatives.
    149. Studies on coumarins from the root of Angelica decursiva FR. et SAV.: II. stereostructures of Decursin, Decursidin, and other new Pyranocoumarin derivatives
    150. Synthesis and biological evaluation of Decursin, prantschimgin and their derivatives
    151. Synthesis and evaluation of (+)-Decursin derivatives as inhibitors of the Wnt/β-catenin pathway
    152. Synthesis of (S)-(+)-Decursin and its analogues as potent inhibitors of melanin formation in B16 murine melanoma cells
    153. The constitution of Decursin, a new coumarin isolated from the root of Angelica decursiva FR. et SAV.(umbelliferae)
    154. The in vitro and in vivo anti-tumor effect of Decursin in estrogen receptor-negative human breast cancer cells occurs via downregulation of Akt signaling pathway
    155. The in vitro and in vivo antitumor effect of Decursin in estrogen receptor-negative human breast cancer cells via downregulation of Akt signaling pathway.
    156. The Neuroprotective Effects of Decursin Isolated from Angelica gigas Nakai Against Amyloid β-Protein-Induced Apoptosis in PC 12 Cells via a Mitochondria-Related …
    157. The optimization of microwave‐assisted extraction of Decursin from Angelica gigas Nakai root
    158. Transport of Decursin and Decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability
    159. Variation of Decursin contents of rootages in floral inhibition cultured Angelica gigas Nakai
    Share
    0
    INTERSTELLAR BLEND
    INTERSTELLAR BLEND

    Related posts

    February 20, 2020

    Wedelolactone


    Read more
    February 20, 2020

    Trichostatin A


    Read more
    February 20, 2020

    Taraxasterol


    Read more

    Comments are closed.

    Recent Posts

    • PPARY2
    • NMDA & ANXIETY & DEPRESSION
    • INFECTOBESITY
    • Anti-Acne effect of Flavonoids and Polyphenols
    • NOOTROPICS
    © 2021 Interstellar Blends | Activate Your Super Powers!. © 2019 Interstellar Blends | Activate Your Super Powers!. All Rights Reserved.

    Mandatory FDA Disclaimer
    Privacy Policy
    Terms and Conditions
    Have Questions?
    Contact Gavin Robert McGowen Here

    Join the following facebook groups to learn more:
    Ultimate Weightloss Challenge , Dry Fasting, Longevity Agents , Interstellar Blend Seven Sages, The Infinitely Postive, THE INTERSTELLAR BLEND CHALLENGE: Fluid Restricted Fasting w/ Superherbs

    Love this Website? Contact David Rodriguez to build you one!